# A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

Study · id `cardio:ct-nct02345044` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02345044](<https://clinicaltrials.gov/study/NCT02345044>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02345044

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 426 participants.

## Technical summary

Registry record NCT02345044. Randomized; quadruple masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 426 participants (enrolled count; ClinicalTrials.gov record NCT02345044, source copy `cardio:ctgov-nct02345044-2019-10-08`, retrieved 2026-10-26)
- Start date: 2015-01 (registry gives no type) (ClinicalTrials.gov record NCT02345044, source copy `cardio:ctgov-nct02345044-2019-10-08`, retrieved 2026-10-26)
- Primary completion: 2015-08 (actual) (ClinicalTrials.gov record NCT02345044, source copy `cardio:ctgov-nct02345044-2019-10-08`, retrieved 2026-10-26)
- Completion: 2015-10 (actual) (ClinicalTrials.gov record NCT02345044, source copy `cardio:ctgov-nct02345044-2019-10-08`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT02345044, source copy `cardio:ctgov-nct02345044-2019-10-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02345044-2019-10-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
- Condition: Essential Hypertension
- Intervention (Drug): CS-3150
- Intervention (Drug): placebo
- Intervention (Drug): eplerenone
- Lead sponsor: Daiichi Sankyo
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Daiichi Sankyo (`cardio:org-daiichi-sankyo`)

## Provenance

Content hash: 3800825ef4063252d37a568e29b9d46624edeed1a2179c847dc4d9de6ade84c7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
